Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies
Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 8, 2008 | Series C | $79M | 1 | Phase4 Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Phase4 Ventures | Yes | Series C |